Navigation Links
Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
Date:12/17/2012

Trenton, ME (PRWEB) December 17, 2012

Bar Harbor BioTechnology (BHB) announced today that it will begin offering its StellARray™ Gene Expression System directly to customers on January 1, 2013. BHB’s inventoried arrays for mouse, rat, chicken and human research will be offered, with C. elegans and zebrafish arrays becoming available by the end of 2013.

“We are excited to work directly with the researchers and laboratories to support them in their important work,” said Robert Phelps, CEO. “We are always looking for new ways to improve on our products and services. Thanks to the support of the Maine Technology Institute, we will be adding C. elegans and zebrafish arrays to our product line, allowing us to provide services and support to laboratories working with these model organisms.”

BHB’s other products and services include XenoQ™ Assays, Global Pattern Recognition™ bioanalysis software and GeneSieve™. The company also offers custom design and laboratory services to its customers.

Bar Harbor BioTechnology is a privately held company that was formed in October 2006 and is located in Trenton, Maine. It offers bioanalysis software and consumables for purposes of genetic research in areas of cancer, stem cell research, immunology, metabolism, and specific neurological disorders.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10236254.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Safe Harbor CPAs Announces New Practice Area, S Corp IRS Audit Defense for Small Business
2. Milo Biotechnology Announces FDA Orphan Drug Designation for AAV1-FS344 for Treatment of Duchenne and Becker Muscular Dystrophy
3. Global Agricultural Biotechnology Industry
4. Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
5. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
6. David Lichtenstein: Biotechnology is Rich Area for Investment
7. Germany Prioritizes Medical Biotechnology with New Initiatives
8. Biomass characterization technology research highlighted in Industrial Biotechnology journal
9. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
10. Global Marine Biotechnology Industry
11. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA ... dose escalation and expansion clinical trial for its lead drug candidate, AC0010, at ... of the trial was to determine the safety, antitumor activity, and recommended phase ...
(Date:12/7/2016)... LANSING, Mich. , Dec. 7, 2016 ... it has named Dr. Dan Kephart as ... the company. Kephart will assume his responsibilities at Neogen ... research and development director for the agribusiness unit of ... food safety development at Life Technologies. His extensive industry ...
(Date:12/7/2016)... 2016  Nordion, a standalone business of Sterigenics ... today,s award by the United States Department of ... the Phase II cooperative agreement funding to GA ... University of Missouri Research Reactor Center (MURR ® ... establishment of a new, reliable supply of molybdenum ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
(Date:11/15/2016)... Research and Markets has announced the addition of the "Bioinformatics ... ... The global bioinformatics market is projected ... in 2016, growing at a CAGR of 21.1% during the forecast ... by the growing demand for nucleic acid and protein sequencing, increasing ...
Breaking Biology News(10 mins):